Jan Novotný

2.3k total citations
61 papers, 1.4k citations indexed

About

Jan Novotný is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Jan Novotný has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 20 papers in Molecular Biology and 15 papers in Genetics. Recurrent topics in Jan Novotný's work include BRCA gene mutations in cancer (11 papers), Genetic factors in colorectal cancer (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). Jan Novotný is often cited by papers focused on BRCA gene mutations in cancer (11 papers), Genetic factors in colorectal cancer (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). Jan Novotný collaborates with scholars based in Czechia, Germany and Italy. Jan Novotný's co-authors include Pavel Vodička, Barbara Pardini, Alessio Naccarati, Kari Hemminki, Asta Försti, Stefano Landi, Ľudmila Vodičková, Zdeněk Kleibl, Debora Landi and Federico Canzian and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Jan Novotný

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Novotný Czechia 21 737 508 406 257 253 61 1.4k
Jana Slyšková Czechia 21 1.1k 1.5× 741 1.5× 342 0.8× 103 0.4× 245 1.0× 38 1.5k
Hidekazu Koike Japan 23 724 1.0× 461 0.9× 327 0.8× 216 0.8× 183 0.7× 91 1.5k
Honglin Song United Kingdom 24 904 1.2× 315 0.6× 441 1.1× 498 1.9× 272 1.1× 41 1.6k
Arancha Cebrián Spain 22 647 0.9× 249 0.5× 320 0.8× 151 0.6× 96 0.4× 50 1.3k
Tadeusz Dębniak Poland 27 699 0.9× 504 1.0× 585 1.4× 690 2.7× 515 2.0× 94 1.9k
Karen Woodson United States 28 1.1k 1.5× 420 0.8× 357 0.9× 371 1.4× 124 0.5× 38 2.0k
Marianna Sarkissyan United States 18 581 0.8× 396 0.8× 429 1.1× 106 0.4× 206 0.8× 23 1.1k
Reiko Makino Japan 23 868 1.2× 293 0.6× 501 1.2× 180 0.7× 300 1.2× 53 1.7k
Yongli Guan United States 18 709 1.0× 513 1.0× 165 0.4× 231 0.9× 172 0.7× 25 1.6k
Yue Wei United States 22 1.1k 1.6× 228 0.4× 367 0.9× 76 0.3× 137 0.5× 83 2.2k

Countries citing papers authored by Jan Novotný

Since Specialization
Citations

This map shows the geographic impact of Jan Novotný's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Novotný with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Novotný more than expected).

Fields of papers citing papers by Jan Novotný

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Novotný. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Novotný. The network helps show where Jan Novotný may publish in the future.

Co-authorship network of co-authors of Jan Novotný

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Novotný. A scholar is included among the top collaborators of Jan Novotný based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Novotný. Jan Novotný is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gkekas, Ioannis, Jan Novotný, Tuomas Kaprio, et al.. (2021). Colon cancer patients with mismatch repair deficiency are more likely to present as acute surgical cases. European Journal of Cancer. 157. 1–9. 3 indexed citations
3.
Meißner, Julia, et al.. (2020). A Severe Case of Anaplastic Large Cell Lymphoma in a Previously Healthy Woman: Diagnostic and Therapeutic Challenges. SHILAP Revista de lepidopterología. 121(4). 262–266.
4.
Novotný, Jan, Aleš Benda, Michael Krause, et al.. (2017). The nematode homologue of Mediator complex subunit 28, F28F8.5, is a critical regulator of C. elegans development. PeerJ. 5. e3390–e3390. 1 indexed citations
5.
6.
Novotný, Jan, et al.. (2015). Perilipin-related protein regulates lipid metabolism in C. elegans. PeerJ. 3. e1213–e1213. 20 indexed citations
7.
Novotný, Jan, et al.. (2014). SKIP and BIR-1/Survivin have potential to integrate proteome status with gene expression. Journal of Proteomics. 110. 93–106. 1 indexed citations
8.
Huhn, Stefanie, Melanie Bevier, Barbara Pardini, et al.. (2014). Colorectal cancer risk and patients’ survival: influence of polymorphisms in genes somatically mutated in colorectal tumors. Cancer Causes & Control. 25(6). 759–769. 14 indexed citations
9.
Pardini, Barbara, Fabio Rosa, Elisa Barone, et al.. (2013). Variation within 3′-UTRs of Base Excision Repair Genes and Response to Therapy in Colorectal Cancer Patients: A Potential Modulation of microRNAs Binding. Clinical Cancer Research. 19(21). 6044–6056. 46 indexed citations
10.
Naccarati, Alessio, Barbara Pardini, Stefano Landi, et al.. (2012). Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk. Carcinogenesis. 33(7). 1346–1351. 54 indexed citations
11.
Kleiblová, Petra, et al.. (2012). Contribution of the β-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity. Pharmacological Reports. 64(5). 1234–1242. 17 indexed citations
12.
Poláková, Veronika, Barbara Pardini, Alessio Naccarati, et al.. (2009). Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Human Mutation. 30(4). 661–668. 47 indexed citations
13.
Kleiblová, Petra, et al.. (2009). Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients. Cancer Chemotherapy and Pharmacology. 65(4). 661–669. 21 indexed citations
14.
Václavíková, Radka, Silje Nord, Grethe I.G. Alnæs, et al.. (2008). Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients. Pharmacogenetics and Genomics. 18(3). 263–273. 19 indexed citations
15.
Campa, Daniele, Pavel Vodička, Barbara Pardini, et al.. (2008). Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk?. European Journal of Cancer. 44(6). 854–857. 9 indexed citations
16.
Landi, Debora, Federica Gemignani, Alessio Naccarati, et al.. (2007). Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis. 29(3). 579–584. 238 indexed citations
17.
Kleibl, Zdeněk, Ondřej Havránek, Jan Novotný, et al.. (2007). Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations. Breast Cancer Research and Treatment. 112(1). 159–164. 24 indexed citations
18.
Halaška, M, et al.. (2006). A method for the detection of post-operative lymphoedema after operation for breast cancer: multifrequency bioelectrical impedance analysis. Journal of Applied Biomedicine. 4(4). 179–185. 4 indexed citations
19.
Kleibl, Zdeněk, Jan Novotný, Radek Malı́k, et al.. (2005). The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic. Breast Cancer Research and Treatment. 90(2). 165–167. 33 indexed citations
20.
Jankú, Filip, Zdeněk Kleibl, Jan Novotný, et al.. (2004). Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer. European Journal of Cancer Supplements. 2(3). 105–105. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jana Slyšková Breakdown of academic impact, for papers by Hidekazu Koike Breakdown of academic impact, for papers by Honglin Song Breakdown of academic impact, for papers by Arancha Cebrián Breakdown of academic impact, for papers by Tadeusz Dębniak Breakdown of academic impact, for papers by Karen Woodson Breakdown of academic impact, for papers by Marianna Sarkissyan Breakdown of academic impact, for papers by Reiko Makino Breakdown of academic impact, for papers by Yongli Guan Breakdown of academic impact, for papers by Yue Wei
Rankless by CCL
2026